A cytokine receptor-targeting chimera toolbox for expanding extracellular targeted protein degradation.

Proc Natl Acad Sci U S A · 2026 · PMC12846780 · PMID 41564137

Europe PMC DOI

hedged sentence

—

closest p

—

boldest claim

The sentences

modest significanceno p-value reported

IL4-Beva significantly increased the number of B cells that took up VEGF-647 (mean 19.4%), of modest significance above all other treatments.

also in 149 other papers

Quoted from the open-access full text in Europe PMC under the licence the publisher applied. The sentence is reproduced exactly as published; the emphasis is ours.